Skip to content
Mark Cuban Cost Plus Drug Company, PBC logo

Mark Cuban Cost Plus Drug Company, PBC

Mark Cuban Cost Plus Drug Company, PBC is a YC Summer 2018 (S18) company.

About Mark Cuban Cost Plus Drug Company, PBC

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Mark Cuban Cost Plus Drug Company, PBC manufactures and sells affordable generic medications that would otherwise carry high prices in the traditional pharmaceutical supply chain. It serves patients and consumers who need generic drugs but face steep costs at conventional pharmacies. The company takes the place of the standard drug pricing model by sourcing and producing generics at a fraction of the typical retail price.

From the Y Combinator listing

How Mark Cuban Cost Plus Drug Company, PBC describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Making low cost versions of high cost generic drugs.

Facts

Industry
Healthcare / Healthcare -> Consumer Health and Wellness
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works